| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/03/2005 | WO2005010032A2 Replikin peptides and uses thereof |
| 02/03/2005 | WO2005010030A2 C5a receptor antagonists |
| 02/03/2005 | WO2005010027A2 Novel peptidic conjugates for alopecia preventive and curative treatment |
| 02/03/2005 | WO2005010022A2 Agonist polypeptide of receptor for zot and zonulin |
| 02/03/2005 | WO2005009477A1 Compositions and methods for treating cardiac dysfunction |
| 02/03/2005 | WO2005009467A1 Chris-like virus, compositions, vaccines and uses thereof |
| 02/03/2005 | WO2005009396A2 Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections |
| 02/03/2005 | WO2005009394A2 Drug delivery in the nervous system |
| 02/03/2005 | WO2005009379A2 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 02/03/2005 | WO2005009378A2 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 02/03/2005 | WO2005009369A2 A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 02/03/2005 | WO2005009366A2 Restoring vascular function |
| 02/03/2005 | WO2005009363A2 Treatment of pre-cancerous conditions and prevention of cancer using pcdgf-based therapies |
| 02/03/2005 | WO2005009358A2 Conformationally constrained parathyroid hormone (pth) analogs |
| 02/03/2005 | WO2005009335A2 Live attenuated nidovirus vaccines |
| 02/03/2005 | WO2005009287A2 Drug delivery to the inner ear and methods of using same |
| 02/03/2005 | WO2005009217A2 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 02/03/2005 | WO2004111251A9 Modified fiber proteins for efficient receptor binding |
| 02/03/2005 | WO2004111244A3 Methods for the production of insulin in plants |
| 02/03/2005 | WO2004110472A3 Fusion proteins |
| 02/03/2005 | WO2004102195A8 Method for identifying tff2 regulating agents and agents identified using said method |
| 02/03/2005 | WO2004099408A8 Novel protein and dna coding for the same |
| 02/03/2005 | WO2004087959A3 Stat-6 gene variants and process of detecting the same |
| 02/03/2005 | WO2004081190A3 Uses of il-23 agonists and antagonists; related reagents |
| 02/03/2005 | WO2004061087A3 Methods and compositions of ecdysozoan molt inhibition |
| 02/03/2005 | WO2004050849A3 Recombinant immunotoxin and use in treating tumors |
| 02/03/2005 | WO2004013289A3 Diagnosis of kidney damage and protection against same |
| 02/03/2005 | WO2004012574A3 Negative selections assays, and compositions thereof |
| 02/03/2005 | WO2004006655A8 Nuclear fertility restorer genes and methods of use in plants |
| 02/03/2005 | WO2004000351A8 Packaged virus-like particles for use as adjuvants: method of preparation and use |
| 02/03/2005 | WO2003099850A3 Mutant p53 (δ126-132) protein and uses thereof |
| 02/03/2005 | WO2003096988A3 Tr4/tr2 response elements |
| 02/03/2005 | WO2003089613A3 Tocopherol associated protein and uses thereof |
| 02/03/2005 | WO2003083084A3 Protein modification and maintenance molecules |
| 02/03/2005 | WO2003081250A8 Novel compositions and methods in cancer associated with altered expression of prlr |
| 02/03/2005 | WO2003070890A3 THE p65 SUBUNIT OF NF-κB FOR THE RADIOSENSITIZATION OF CELLS |
| 02/03/2005 | WO2003059257A8 Anti-angiogenic proteins and fragmentsand methods of use thereof |
| 02/03/2005 | WO2003037248A3 Fibrin nanoparticles and uses thereof |
| 02/03/2005 | WO2003025153A3 Enhanced proteins and methods for their use |
| 02/03/2005 | WO2003025143A3 Maxp1 |
| 02/03/2005 | WO2003022992A3 Mammalian genes; related reagents |
| 02/03/2005 | WO2002102235A3 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer |
| 02/03/2005 | WO2002099119A3 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 02/03/2005 | WO2002092837A3 Nucleic and molecule associated with prostate cancer and melanoma immunodetection and immunotherapy |
| 02/03/2005 | WO2001048228A8 Methods and materials relating to gene expression |
| 02/03/2005 | WO2001025401A3 A mycobacterium tuberculosis coding sequence for expression of heterologous proteins |
| 02/03/2005 | US20050028235 Plant fruit with elevated potassium levels |
| 02/03/2005 | US20050028232 Recombination polypeptide for use as gene transfer tool in plant genetic engineering; tissue engineering |
| 02/03/2005 | US20050028231 Nucleotide sequences coding X-ray repair cross-complementing polypeptide for use in enhancing DNA single-strand break repair in plants |
| 02/03/2005 | US20050028230 Expresion vector comprising nucleotide sequences coding membrane glycoprotein for use in generation of transgenic animal models for identifying modulators which reduce concentration of preferential biological agents in tissues of cells |
| 02/03/2005 | US20050028227 Bile salt export pump (BSEP); antibodies; gene expression inhibition; drug screening; high throughput assay; host cells |
| 02/03/2005 | US20050027457 Biosynthesis of amino acid sequences; rearrangement of peptide; ; |
| 02/03/2005 | US20050027114 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 02/03/2005 | US20050027113 Compositions and methods relating to the daptomycin biosynthetic gene cluster |
| 02/03/2005 | US20050027110 Nontoxic lectin conjugated to therapeutic agent for use in treatment and prevention of nervous system disorders |
| 02/03/2005 | US20050027109 Preparing genetically engineered therapeutic protein fusion comprised of antibody constant region for use in treatment of metabolic disorders |
| 02/03/2005 | US20050027104 Antibodies for use in diagnosis, prevention and treatment of autoimmune disease |
| 02/03/2005 | US20050027103 Matrix protein for use diagnosis, treatment, and prevention of viral infections, cell proliferative and neurological disorders |
| 02/03/2005 | US20050026863 Delivery of therapeutic gene products by intestinal cell expression |
| 02/03/2005 | US20050026841 Hab18g/cd147 its antagonist and application |
| 02/03/2005 | US20050026839 Conformationally constrained parathyroid hormone (pth) analogs |
| 02/03/2005 | US20050026838 Fibroblast Growth Factor-13 |
| 02/03/2005 | US20050026837 Novel proteins and methods for producing the proteins |
| 02/03/2005 | US20050026834 Methods for making proteins containing free cysteine residues |
| 02/03/2005 | US20050026833 PSP-94: use for treatment of hypercalcemia and bone metastasis |
| 02/03/2005 | US20050026831 inhibitors of notch signalling comprising proteins or polypeptides having notch ligand domains, multimeric proteins or polynucleotide codes for the protein or polypeptides, used in the treatment of cancer; vaccines |
| 02/03/2005 | US20050026829 Methods and compositions for selective modulation of vascularization |
| 02/03/2005 | US20050026828 Methods for modulating gastric secretion using prokineticin receptor antagonists |
| 02/03/2005 | US20050026827 Octapeptide bombesin analogs |
| 02/03/2005 | US20050026826 Feline proinsulin, insulin and constituent peptides |
| 02/03/2005 | US20050026825 Receptor |
| 02/03/2005 | US20050026823 Use of the chaperone receptor-associated protein (RAP) for the delivery of therapeutic compounds to the brain and other tissues |
| 02/03/2005 | US20050026822 Human 3 relaxin |
| 02/03/2005 | US20050026817 peptide nucleic acids used as gene expression inhibitors and as probes for detection of nucleic acids |
| 02/03/2005 | US20050026815 administering to mammals genetic engineered glycoproteins for therapy of autoimmune disease selected from Addison's disease, Crohn's disease, Graves' disease, psoriasis, scleroderma, ulcerative colitis, or aquired immune deficiency syndrome |
| 02/03/2005 | US20050026293 Autonomously replicating biomolecule for use as gene transfer tool in genetic engineering |
| 02/03/2005 | US20050026292 GLYT1 conditional knock-out mice |
| 02/03/2005 | US20050026291 System for expression of genes in plants |
| 02/03/2005 | US20050026280 Arabidopsis thaliana mutant for use as plant model for monitoring light absorption and photosynthesis in plants |
| 02/03/2005 | US20050026272 Non-toxic immune stimulating enterotoxin compositions |
| 02/03/2005 | US20050026271 subunit vaccines for dental caries; rather than using intact GTF as an immunizing agent, the vaccine is prepared from particular immunogenic portions (subunits) of GTF |
| 02/03/2005 | US20050026266 Methods to identify agents modulating functions of polypeptide galnac-transferases, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments |
| 02/03/2005 | US20050026264 An Asparagine106-glycosylated chicken cystatin having Isoleucine-108 replaced by Threonine-108 has improved freeze resistance as well as improved heat resistance; nonbiodegradable; nonsoftening gel; food processing of surmi comprising preferably nemipterid, mackerel or cod |
| 02/03/2005 | US20050026256 Aspartyl protease for use as tool in identifying modulators for use in treatment and prevention of nervous system disorders |
| 02/03/2005 | US20050026254 Novel human growth factors |
| 02/03/2005 | US20050026253 Adipogenesis inhibitory factor for use as tool in identifying modulators for prevention and treatment of obesity |
| 02/03/2005 | US20050026252 Expression vector comprising rodent regulatory sequences for use as gene expression control tools in genetic engineering |
| 02/03/2005 | US20050026251 Netrin receptor protein for use in identification of modulator for use in treatment and prevention of infection, nervous system, autoimmune, inflammatory, psycological and reproductive disorders |
| 02/03/2005 | US20050026248 Expression vector comprising nucleotide sequences coding membrane protein with leucine rich regions for use as tool in generating animal models for study of cell proliferative disorders |
| 02/03/2005 | US20050026247 Using trangenic escherichia to generate bone morphogenic protein for use in treatment and prevention of nervous system, dental, skin, connective tissue and bone disorders; wound healing agents |
| 02/03/2005 | US20050026243 Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity and related disorders |
| 02/03/2005 | US20050026234 Chimeric phosphorylation indicator comprising fluorescent protein and phosphoaminoacid binding domain for use as diagnostic indicator of kinase activity in different compartments of organelles |
| 02/03/2005 | US20050026232 Monoclonal antibody which preferentially binds leukocyte common antigen-related molecule phosphatase (LAR) for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 02/03/2005 | US20050026229 Cell line for use in generating monoclonal antibodies specific for prostate stem cell antigen (PSCA) for use in diagnosis of cell proliferative disorders; immunodiagnostics |
| 02/03/2005 | US20050026228 Using concentration of receptor protein tyrosine kinase polypeptide/adaptor complex as diagnostic indicator of cell proliferative disorders; turmor diagnosis and treatment |
| 02/03/2005 | US20050026226 Serum Paraoxonase |
| 02/03/2005 | US20050026220 Isolation and mobilization of stem cells expressing vegfr-1 |
| 02/03/2005 | US20050026218 Expression vector comprising nucleotide sequences coding type IV secretion system proteins (T4SS) for use in identifying modulator for treatment of rickettsia infection |
| 02/03/2005 | US20050026216 Compositions and methods for detecting multidrug resistant strains of M. tuberculosis having mutations in genes of the mutT family |
| 02/03/2005 | US20050026213 Mammalian Galanin receptors |